PLASMA PROLACTIN, ADRENOCORTICOTROPIC HORMONE AND CORTISOL AFTER ADMINISTRATION OF D-FENFLURAMINE OR PLACEBO TO HEALTHY-SUBJECTS

被引:34
作者
GORARD, DA
TAYLOR, TM
MEDBAK, SH
PERRY, LA
LIBBY, GW
FARTHING, MJG
机构
[1] ST BARTHOLOMEWS HOSP,DEPT CHEM ENDOCRINOL,LONDON EC1A 7BE,ENGLAND
[2] ST BARTHOLOMEWS HOSP,DEPT REPROD PHYSIOL,LONDON EC1A 7BE,ENGLAND
关键词
D-FENFLURAMINE; HORMONAL RESPONSE; 5-HYDROXYTRYPTAMINE;
D O I
10.1097/00004850-199300820-00008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hormonal responses following single doses of the racemic drug d,l-fenfluramine have been used as an index of central 5-hydroxytryptamine (5-HT) function. We wished to evaluate normal responses to d-fenfluramine, which is more specific at stimulating 5-HT pathways. Twelve healthy volunteers were given 30 mg oral d-fenfluramine and placebo in a randomized single-blind crossover design. Following d-fenfluramine there was a rise in plasma prolactin, but no ACTH response. Cortisol levels did not rise above baseline values, but d-fenfluramine diminished the circadian fall in cortisol output, and cortisol levels were slightly higher after d-fenfluramine than after placebo. Unlike d,l-fenfluramine, d-fenfluramine is not a potent stimulus for ACTH and cortisol release. Hormonal responses following d-fenfluramine provide a more accurate assessment of the functional integrity of central 5-HT activity.
引用
收藏
页码:123 / 128
页数:6
相关论文
共 33 条
[1]   THE EFFECTS OF GEPIRONE ON NEUROENDOCRINE FUNCTION AND TEMPERATURE IN HUMANS [J].
ANDERSON, IM ;
COWEN, PJ ;
GRAHAMESMITH, DG .
PSYCHOPHARMACOLOGY, 1990, 100 (04) :498-503
[2]   THE NEURO-ENDOCRINE RESPONSE TO FENFLURAMINE IN DEPRESSIVES AND NORMAL CONTROLS [J].
ASNIS, GM ;
EISENBERG, J ;
VANPRAAG, HM ;
LEMUS, CZ ;
FRIEDMAN, JMH ;
MILLER, AH .
BIOLOGICAL PSYCHIATRY, 1988, 24 (01) :117-120
[3]  
COPPEN A, 1972, ARCH GEN PSYCHIAT, V26, P474
[4]   MEASUREMENT OF CIRCULATING CORTICOTROPIN-RELEASING FACTOR IN MAN [J].
CUNNAH, D ;
JESSOP, DS ;
BESSER, GM ;
REES, LH .
JOURNAL OF ENDOCRINOLOGY, 1987, 113 (01) :123-131
[5]  
DEBBAS NMG, 1985, BRIT J CLIN PHARM, V20
[6]   PHARMACOLOGICAL CHARACTERIZATION OF SEROTONIN RECEPTORS INVOLVED IN THE CONTROL OF PROLACTIN SECRETION [J].
DIRENZO, G ;
AMOROSO, S ;
TAGLIALATELA, M ;
CANZONIERO, L ;
BASILE, V ;
FATATIS, A ;
ANNUNZIATO, L .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 162 (02) :371-373
[7]   PARAVENTRICULAR NUCLEUS SEROTONIN MEDIATES NEURALLY STIMULATED ADRENOCORTICAL SECRETION [J].
FELDMAN, S ;
CONFORTI, N ;
MELAMED, E .
BRAIN RESEARCH BULLETIN, 1987, 18 (02) :165-168
[8]   EVIDENCE THAT THE MEDIAL AND DORSAL RAPHE NUCLEI MEDIATE SEROTONERGICALLY-INDUCED INCREASES IN PROLACTIN-RELEASE FROM THE PITUITARY [J].
FESSLER, RG ;
DEYO, SN ;
MELTZER, HY ;
MILLER, RJ .
BRAIN RESEARCH, 1984, 299 (02) :231-237
[9]   SEROTONERGIC STIMULATION OF PITUITARY-ADRENOCORTICAL FUNCTION IN RATS [J].
FULLER, RW .
NEUROENDOCRINOLOGY, 1981, 32 (02) :118-127
[10]  
GARATTINI S, 1975, POSTGRAD MED J, V51, P27